Levodopa: alterations in behavior.
D000275:Adjustment Disorders / Q000188:drug therapy*; D000368:Aged; D000786:Anger / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006018:Glycols / Q000652:urine; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D010919:Placebos; D013997:Time Factors; D014642:Vanilmandelic Acid / Q000652:urine
D006018:Glycols; D006834:Hydrazines; D010648:Phenylacetates; D010919:Placebos; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine